CHIPTS

Projects focused on any aspect of #HIV research from all research disciplines will be considered (e.g., basic, clinical, behavioral, policy, implementation science, social science etc.). Access the RFA: cfar.ucla-cdu.org/wp-content/u...

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons - PubMed The HIV incidence with twice-yearly lenacapavir was significantly lower than the background incidence and the incidence with F/TDF. (Funded by Gilead Sciences; PURPOSE 2 ClinicalTrials.gov number, NCT...

Access this paper featuring Dr. Jesse Clark, CHIPTS Development Core Director - "Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons." Findings showed that #HIV incidence with twice-yearly #lenacapavir was lower than incidence with F/TDF. pubmed.ncbi.nlm.nih.gov/39602624/

For those interested in applying, #UCGHI is offering a #GloCalHealthFellowship informational webinar on Friday, August 15, 2025, from 7-8 AM PT! Learn more about the current application cycle from #UCGHI GloCal Director, Dr. Craig Cohen. Register here: ucsf.zoom.us/meeting/regi...

Dr. Landovitz's #IASUSA webinar on "Complicated Issues in the Management of PrEP," has been extended to a 2nd session as much discussion was left on challenges in new data and #PrEP options. Join for part 2 of the webinar on August 28, 2025. Learn more: www.iasusa.org/courses/on-d...

Check out this exciting seminar hosted by @hucfar.bsky.social part of their ESI Talk series on Thursday, August 21, 2025, from 10AM-12PM PT! The talk features Dr. Koofhethile (@HarvardChanSPH) who will discuss advancing #HIV cure research in Botswana. Register: mailchi.mp/045e6a7de3e4...

The UCLA-CDU CFAR and the UCLA AIDS Institute are accepting applications for their Pilot Projects designed for early-career investigators, Letters of Intent (LOIs) are being evaluated until deadline on Friday, September 12, 2025. Learn more: cfar.ucla-cdu.org/pilot-projec...

The @ucghi.bsky.social is now accepting applications for their #GloCalHealthFellowship! The fellowship cultivates a supportive environment where researchers are equipped with the tools to address pressing health challenges. Apply by Sept. 15, 2025! ucghi.universityofcalifornia.edu/fellowships/...

For those interested in our #HIVGrandRounds series, we encourage you to visit our website to get more information about the series and upcoming sessions (as details become available). Also available is our recordings from previous sessions. Learn more: chipts.ucla.edu/training/hiv...

Registration for the #SDCFAR Research Day on Sept. 11, 2025, at 9 AM PT, in San Diego is now open! The research day aims to highlight groundbreaking discoveries that are transforming the landscape of #HIV research, treatment, and prevention. Register here: ucsd.co1.qualtrics.com/jfe/form/SV_...

Don't forget to check out the 8 papers from our UCLA 3R IS Hub investigators featured in the 2025 #JAIDS supplemental issue released in mid-April! The issue examined key findings and takeaways from 120 #EHE projects across 40 priority jurisdictions. Read here: journals.lww.com/jaids/toc/20...

Join our #ICYMI session sharing highlights of #IAS2025 on Wednesday, August 6, 2025, from 2-3 PM PT! We welcome students, community members, healthcare providers, policymakers, researchers, and anyone interested to join. Register here: bit.ly/ICYMI2025

We strongly encourage proposals for the 2026 Mentored Pilot Grant Program that contribute towards CHIPTS scientific theme of #HIV treatment and prevention, #MentalHealth, and/or #SubstanceUse co-morbidities. Learn more: chipts.ucla.edu/pilot-mentor...

Letters of Intent (LOIs) are currently being accepted for
#GileadSciences Research to Advance #HIV Treatment Outcomes (RESONATE) RFP Program, the LOI’s are being evaluated monthly until the deadline on November 3, 2025, at 11:59 PM PT. Learn more: gilead.com/-/media/file...

Don't forget today (July 21st) is the last day to submit abstracts for the #SDCFAR Research Day in San Diego. The conference theme is "Resilience in #HIV Research and Treatment: Progress and Possibilities."

Our colleagues at @ucsfprevention.bsky.social have announced The iVY Study - A cutting-edge research initiative. The project focuses on enhancing health and well-being through short video counseling sessions and a mobile health app. Sessions are done remotely. Learn more: ivy.ucsf.edu

We are excited to share that some of our amazing CHIPTS investigators that are in attendance at #IAS2025 are planning to share key highlights from the conference in an #ICYMI session designed for our #CHIPTS community. Register here: bit.ly/ICYMI2025

A comprehensive list of all featured abstracts from the 13th IAS Conference on #HIV Science ( #IAS2025) in Kigali, Rwanda is available in the Journal of the International AIDS Society ( #jiasociety). Access this helpful resource: onlinelibrary.wiley.com/toc/17582652...

An inspiring press release was shared following a press conference on the opening day of #IAS2025. The press release captures #IAS2025's efforts in spotlighting scientific progress, funding challenges and calls to action by committed leaders. Read more: iasociety.org/news-release...

Now accepting applications for the 2026 Mentored Pilot Grant Program for emerging investigators. This grant will support applicants in obtaining individualized, mentored research from a committed faculty mentor. Deadline is September 2, 2025! Learn more: chipts.ucla.edu/pilot-mentor...

Abstract submission deadline has been extended for the #SDCFAR Research Day taking place on Thursday, September 11, 2025, in San Diego. The abstract submission deadline is on Monday, July 21, 2025. Learn more about the Research Day and how to submit an abstract: cfar.ucsd.edu/en/meetings/...

Check out this upcoming #IASUSA webinar featuring CHIPTS Center Co-Director, Dr. Raphael Landovitz who will describe the management of challenging cases, including #HIV infection diagnosis within the context of #PrEP and breakthrough infection. Register here: www.iasusa.org/events/webin...

We are excited to announce the CHIPTS HIV Next Generation Conference (#HIVNextGen) on Feb. 5, 2026. If you're interested in attending, please save the date and subscribe to our email listserv for updates on registration and abstract submissions. Subscribe: forms.gle/xYex4wm8nETL...

The #HHSGov panel on treatment of #HIV during pregnancy and prevention of perinatal transmission has reviewed and updated guidelines sections to address new data and publications. Learn more: bit.ly/4mXVu3K

Want to keep up with the latest information from CHIPTS, including HIV-related research, trainings, and events? #HIVAwareness #HIVPrevention

Subscribe to our CHIPTS email listserv by filling out our Google Form! forms.gle/6z76Zqa4KSsu...

NIH funding cuts to implementation science slowing progress on HIV - WashU School of Public Health Implementation research has been critical driver toward ending HIV epidemic, says WashU's Elvin Geng.

#Impsci scientists including Elvin Geng from #WashU published an analysis that shows that 52 #impsci grants were cut from Feb-Apr, totaling more than $165m and affecting 51,381 study participants at 195 care-delivery sites in the U.S., Asia and Africa. schoolofpublichealth.washu.edu/nih-funding-...

The webtool team is requesting support in expanding and enhancing the D&I Models in Health Webtool, which is an interactive, online resource designed to help researchers and practitioners navigate D&I theories, models, and frameworks. Assess instruments: dissemination-implementation.org/tool/assess/

Dr. Raphael Landovitz, Director of CHIPTS, and colleagues part of #IASUSA Antiretroviral Guidelines Panel published an article on @jamanetworkopen.com that shares updates to their 2024 recommendations for the prevention of #HIV infection. Read here: jamanetwork.com/journals/jam...

Let's Get Tested! Get FREE HIV, syphilis and hep C testing at select Walgreens on June 27th!

Today is #HIVTestingDay! @kff.org and Walgreens are partnering with 415 health departments and community organizations to produce the largest-ever National HIV Testing Day activation at 575 stores today. Find free testing near you: bit.ly/4jK9vPI

Tens of Thousands Still Struggle to Access Long-Acting HIV Treatment in U.S. While some barriers are gradually diminishing over time, availability and affordability remain inconsistent in many states, particularly outside urban areas and well-staffed sexual health clinics.

An article by @bodyprohiv.bsky.social finds that after the first long-acting #HIV treatment was approved, people in many parts of the U.S. still struggle to get medications. While barriers are diminishing over time, availability and affordability remain inconsistent in many states. bit.ly/3SZxYFT

The Center for Dissemination and Implementation at Stanford (C-DIAS) has posted the recording and slide of the recent C-DIAS PSMG Virtual Grand Rounds on their website. The session was in collaboration with our UCLA IS Hub and featured Dr. Alison Hamilton. c-dias.org/presentation...